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Abstract
Novel semisynthetic analogs of salvinorin A, a full agonist having extraordinary affinity as well as
selectivity for the κ-opioid receptor (KOR), were obtained in good yields. The derivatives are
remarkable for their unusual and unique hemiacetal structure in the salvinorin series of compounds.
The formation of the hemiacetal occurs with epimerization at C-12, thus preserving the original
configuration of salvinorin A. The dimethyl ester derivative of the hemiacetal was found to have an
affinity for both KOR and MOR (μ-opioid receptor).
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Salvinorin A, a secondary metabolite isolated from the leaves of Salvia divinorum, is a
neoclerodane diterpenoid with a strong hallucinogenic activity. It has been shown to have high
affinity and selectivity for KOR.1 Salvinorin A represents an attractive lead compound for
drug development due to its strong effects on human mood and low toxicity. In the last two
years numerous derivatives and analogs of salvinorin A were synthesized showing a broad
range of KOR affinities.2 Synthesis of new analogs of salvinorin A is important for generating
structure-receptor affinity data and for design of agents with therapeutic potential. Some of the
chemical modifications of salvinorin A have produced analogs with changed pharmacological
profiles from full κ-agonist to partial δ- or μ-agonists or antagonists.2i,2m,3 Recently,
modifications of the furan ring yielded the first analogs with κ-antagonistic activity.2b
In this paper we report the synthesis of the hemiacetal (2) and its derivatives starting from
salvinorin A. Refluxing 1 with 5% aqueous KOH surprisingly gave only one product according
to thin-layer chromatography.4 (Scheme 1).
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1H and 13C NMR analysis of the isolated product showed the typical spectra of salvinorins
with an opened lactone moiety, except for the lack of the ketone carbon resonance at δ 200.
Instead, a new resonance appeared at δ 97 suggesting the presence of carbon connected to two
oxygen atoms. Interestingly, under the harsh basic conditions, we did not observe epimerisation
at C-8, commonly occurring in salvinorins.2d,5
The proposed mechanism of hemiacetal formation with (R)-configuration at C-12 includes
formation of acyclic alcohol (3), rotation along the C-11-C-12 bond, leading to conformer
(4), cyclization to the hemiacetal with (S)-configuration at C-12 (5) and epimerization at C-12
via intermediate 6 to the thermodynamically more stable product (2). Although the reaction is
performed in an alkaline medium, the intermediate 6 is still anticipated to be stabilized by
solvation.
An alternative mechanism assumes a 1,5-hydride shift in the hydroxyacid intermediate 4,
followed by a retro 1,5-hydrid shift in 7 to form an epimeric hydroxyacid (8) as a precursor to
hemiacetal 2. (Scheme 2)
The absolute configuration has been unambiguously determined by X-ray crystallographic
analysis6 of the corresponding dimethyl ester (9)7 (Figure 2).
Considering the importance of the acetoxy group at C-2 for high affinity of salvinorin A to κ-
opioid receptor, we synthesized acetate (10) using acetic anhydride and a catalytic amount of
DMAP.8 (Scheme 3)
Hemiacetals 2 and 9 are relatively stable under basic and neutral conditions. In the presence
of acids diester (9) is readily transformed to the corresponding hydroxyketone (11).
Compounds 2 and 9–11 were evaluated for KOR and MOR affinities at the NIMH-sponsored
Psychoactive Drug Screening Program, University of North Carolina at Chapel Hill using
radioligand binding assays. The assays were conducted according to the procedure described
earlier.1 The results are presented in Table 1.
Transformation of salvinorin A (1) to hemiacetal (2) results in a loss of all KOR activity.
Compound 9 displays moderate affinity for both κ- and μ-opioid receptors. Surprisingly, the
product of acetylation (10), despite functional similarity to salvinorin A, is practically devoid
of affinity. Conversion of the hemiacetal (9) into the acyclic hydroxyketone (11) resulted in
the loss of MOR affinity, while retaining a weak KOR activity.
In summary, we have developed a short synthetic approach to new salvinorin A analogs with
cyclic hemiacetal structure and dual but rather weak affinity to KOR and MOR. This method
offers an attractive strategy to a new and unique class of salvinorin A analogs.
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pressure afforded hydroxyketone (11) which was purified by column chromatography using a short
silica column and hexanes:ethyl acetate (3:2). Yield was 8.1 mg (81%).
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Key HMBC and NOESY correlations of 2
Bikbulatov et al. Page 5














X-ray crystallographic structure of the dimethyl ester (9) [dimethyl (2R,3aR,4R,6aR,7R,9S,
9aS,9bS)-2-(3-furyl)-9,9adihydroxy-3a,6a-dimethyldodecahydrobenzo[de]chromene-4,7-
dicarboxylate]
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Conversion of salvinorin A (1) to hemiacetal (2) under the basic conditions
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Putative mechanisms for hemiacetal (2) formation
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Derivatives of hemiacetal 2
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Table 1
Affinity KOR and MOR receptors (for KOR-[3H]U69593 and MOR-[3H] DAMGO)
Compound Ki (nM) (KOR) Ki (nM) (MOR)
Salvinorin A (1) 0.48+/− 0.18 --
Hemi-acetal (2) NA NA
Diester (9) 219+/−59 1926+/−147
Acetate (10) 6003+/−1242 7487+/−2141
Hydroxyketone (11) 1991+/−708 >10,000
DAMGO -- 2.40+/−0.48
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